SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-122215
Filing Date
2024-04-29
Accepted
2024-04-29 16:05:53
Documents
13
Period of Report
2024-04-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d810575d8k.htm   iXBRL 8-K 28194
  Complete submission text file 0001193125-24-122215.txt   152791

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA stok-20240429.xsd EX-101.SCH 2880
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE stok-20240429_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stok-20240429_pre.xml EX-101.PRE 11278
16 EXTRACTED XBRL INSTANCE DOCUMENT d810575d8k_htm.xml XML 3627
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 24890614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)